NCT04501120 2025-09-26
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
Ascentage Pharma Group Inc.
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT06423911 2025-06-03
POLARIS-2
Ascentage Pharma Group Inc.
Phase 3 Recruiting
NCT03594422 2025-02-27
A Study of HQP1351 in Patients With GIST or Other Solid Tumors
Ascentage Pharma Group Inc.
Phase 1 Recruiting
NCT06640361 2024-12-27
A Study of Olverembatinib in SDH-deficient GIST.
Ascentage Pharma Group Inc.
Phase 3 Recruiting